Literature DB >> 12732088

Complete revascularization in patients with severe left ventricular dysfunction.

Hiroyuki Nishi1, Satoru Miyamoto, Shuichiro Takanashi, Hirokazu Minamimura, Takumi Ishikawa, Yoshihiro Shimizu.   

Abstract

OBJECTIVE: This study evaluates whether patients with coronary artery disease and severely depressed left ventricular ejection fraction (LVEF) benefit from complete revascularization by multivessel coronary artery bypass.
METHODS: From April 1994 to May 2002, 42 patients who underwent coronary artery bypass grafting (CABG) at our institution had impaired left ventricular (LV) function [an ejection fraction (EF) of 30% or less]. The average preoperative LVEF was 23.8%. The mean number of grafts was 4.6. Complete revascularization by multivessel bypass grafting was the goal for all patients.
RESULTS: Thirty days mortality was 0 and hospital mortality was 2.4%. The mean graft patency rate for 35 (83%) patients at one month was 98.8%. The mean postoperative LVEF improved significantly, from 23.8% to 35.2% (p<0.05), and the New York Heart Association (NYHA) classification was improved in most patients. The Kaplan-Meier estimate of survival at 5 years was 83.1%, and that of the cardiac event-free rate at 5 years was 77.5%.
CONCLUSION: For patients with poor LV function, complete surgical revascularization by multivessel bypass grafting can be performed safely, with satisfactory hospital mortality and long-term results.

Entities:  

Mesh:

Year:  2003        PMID: 12732088

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  2 in total

1.  Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies.

Authors:  Vijayalakshmi Kunadian; Azfar Zaman; Weiliang Qiu
Journal:  Eur J Heart Fail       Date:  2011-04-08       Impact factor: 15.534

2.  Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction.

Authors:  André L Hovnanian; Alexandre de Matos Soeiro; Carlos Vicente Serrano; Sérgio Almeida de Oliveira; Fábio B Jatene; Noedir A G Stolf; José A F Ramires
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.